Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 379-383

  Newman Tancredi, Adrian ^a   Audinot Bouchez, Valérie ^a   Gobert, Alain ^a   Millan, Mark J ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

35S GTP S; Adrenaline; Clozapine; Dopamine D4 receptor; L 745,870; Noradrenaline

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; ADRENALIN; CLOZAPINE; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HALOPERIDOL; NORADRENALIN; SEROTONIN; SPIPERONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CHO CELLS; CRICETINAE; DOPAMINE AGONISTS; EPINEPHRINE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; NOREPINEPHRINE; PYRIDINES; PYRROLES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SULFUR RADIOISOTOPES; THERMODYNAMICS;

EID: 0031037070     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00985-5     Document Type: Article

References (21)

1. Carboni, E., G.L. Tanda, R. Frau and G. Di Chiara, 1990, Blockade of the noradrenaline carrier increases extracellular concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals, J. Neurochem. 55, 1067.
2. 5 dopamine receptors, J. Neurochem. 66, 222.
3. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways, J. Pharmacol. Exp. Ther. 275, 899.
4. Hadcock, J.R. and C.C. Malbon, 1993, Agonist regulation of gene expression of adrenergic receptors and G-proteins, J. Neurochem. 60, 1.
5. Hieble, J.P., W.E. Bondinell and R.R. Ruffolo, 1995, α- and β-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification, J. Med. Chem. 38, 3415.
6. Hornykiewicz, O., 1982, Brain catecholamines in schizophrenia - a good case for noradrenaline, Nature 299, 484.
7. Kenakin, T., 1995, Agonist-receptor efficacy. II: Agonist trafficking of receptor signals, Trends Pharmacol. Sci. 16, 232.
8. 4 receptor, J. Med. Chem. 39, 1941.
9. 4.4 receptor, Am. Soc. Neurosci. 21, 252.2.
10. 3H]-NGD-94-1, Am. Soc. Neurosci. 22, 621.14.
11. 4 receptor, Mol. Brain Res. 29, 157.
12. 4 receptor in human cerebral cortex and striatum, J. Neurochem. 66, 915.
13. Moore, R.Y. and F.E. Bloom, 1979, Central catecholamine neuron system: anatomy and physiology of the norepinephrine and epinephrine systems, Annu. Rev. Neurosci. 2, 113.
14. 4 receptors in GABAergic neurons of the primate brain, Nature 381, 245.
15. 4 dopamine receptors in postmortem striatum from patients with schizophrenia, J. Neurosci. 15, 2186.
16. Odagaki, Y., S. Dasgupta and K. Fuxe, 1995, Additivity and non-additivity between dopamine-, norepinephrine-, carbachol- and GABA-stimulated GTPase activity, Eur. J. Pharmacol. 291, 245.
17. 4 receptors in schizophrenia? J. Neurochem. 66, 882.
18. 125I]epidepride, Eur. J. Pharmacol. 286, R3.
19. Van der Graaf, P.H., P.R. Saxena, N.P. Shankley and J.W. Black, 1995, Exposure and characterisation of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries, Br. J. Pharmacol. 116, 3237.
20. Van Kammen, D., J. Peters, J. Yao, W.B. Van Kammen, T. Neylan, D. Shaw and M. Linnoila, 1990, Norepinephrine in acute exacerbations of chronic scizophrenia, Arch. Gen. Psychiatry 47, 161.
21. 4 receptor with high affinity for the antipsychotic clozapine, Nature, 350, 610.